Precision Biosciences (DTIL) Operating Income Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,386.07% |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - | 58.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.96% |
| Dec 31, 2025 | 150.34% |
| Sep 30, 2025 | 2.86% |
| Jun 30, 2025 | -190.60% |
| Mar 31, 2025 | -428.11% |
| Dec 31, 2024 | -66.86% |
| Sep 30, 2024 | -72.09% |
| Jun 30, 2024 | 871.68% |
| Mar 31, 2024 | 68.65% |
| Dec 31, 2023 | -22.97% |
| Sep 30, 2023 | 15.76% |
| Jun 30, 2023 | 89.41% |
| Mar 31, 2023 | 51.15% |
| Dec 31, 2022 | 60.59% |
| Sep 30, 2022 | -27.15% |
| Jun 30, 2022 | -236.62% |
| Mar 31, 2022 | -45.85% |
| Dec 31, 2021 | -30.85% |
| Sep 30, 2021 | 55.68% |
| Jun 30, 2021 | 165.94% |
| Mar 31, 2021 | 31.84% |
| Dec 31, 2020 | -7.41% |
| Sep 30, 2020 | -18.50% |
| Jun 30, 2020 | -37.44% |
| Mar 31, 2020 | -41.05% |
| Dec 31, 2019 | -35.74% |
| Sep 30, 2019 | -110.38% |
| Jun 30, 2019 | -96.87% |
| Mar 31, 2019 | -111.09% |